0000899243-20-034670.txt : 20201221 0000899243-20-034670.hdr.sgml : 20201221 20201221135400 ACCESSION NUMBER: 0000899243-20-034670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201217 FILED AS OF DATE: 20201221 DATE AS OF CHANGE: 20201221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krauss Adam CENTRAL INDEX KEY: 0001836505 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 201403513 MAIL ADDRESS: STREET 1: 139 GRANIT STREET CITY: MEDFIELD STATE: MA ZIP: 02052 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-17 0 0001098972 AGENUS INC AGEN 0001836505 Krauss Adam C/O AGENUS INC., 3 FORBES ROAD LEXINGTON MA 02421 0 1 0 0 Chief Legal Officer Stock Option, (Right to buy) 3.70 2020-12-17 4 A 0 50000 0.00 A 2030-12-17 Common Stock 50000 50000 D Stock Option awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan. One-third of the Stock Option vests on December 17, 2021, with the remaining vesting in eight equal quarterly installments thereafter (provided Mr. Krauss maintains a service relationship with the Company through each such vesting date). /s/ Adam Krauss 2020-12-21